Zhejiang Jinfukang Biotechnology Co., Ltd., founded in July 2012 and located in Hangzhou, China, is a bio high-tech enterprise dedicated to research, development, production and sales of new targeted molecular technologies and cancer series molecular diagnostic products. The core technology of the company is a new technology for detection of RNA, telomere, telomerase, and telomere extension replacement mechanism with new efficient nucleic acid amplification as the core, which is suitable for developing into a series of products, including related cancer molecular diagnosis and scientific research service products. These technologies have completely independent intellectual property rights and are at the international leading level.